Schedule 13G ownership disclosure
ZYNERBA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 98986X109
Event date: 2022-02-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,526,304
- Percent of class
- 8.5600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-22-007453
- Form type
- SC 13G
- Filer
- ETF MANAGERS GROUP, LLC
- CIK
- CIK 1645173
- Filed
- Feb 14, 2022
- Reporting period
- Feb 11, 2022
- Description
- Schedule 13G beneficial ownership